ASML Earnings: Bookings Surge, Lifts 2026 Guidance

ASML earnings show Q4 bookings lifted 2026 sales guidance and may drive renewed investor demand for EUV-exposed chip-equipment names.

January 28, 2026·2 min read
View all news articles
Flat vector of a semiconductor stepper device surging forward to suggest bookings-driven guidance and ASML earnings momentum.

KEY TAKEAWAYS

  • Q4 net bookings totaled €13.2 billion and anchored the company's outlook.
  • Company raised 2026 sales guidance to €34-39 billion, implying up to 19% growth.
  • Bookings reflect AI-driven chipmaker capex and ASML's EUV equipment dominance.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

ASML earnings released on Jan. 28, 2026, showed stronger-than-expected bookings and raised sales guidance for 2026, signaling sustained demand for its extreme-ultraviolet (EUV) lithography systems as chipmakers accelerate AI-related capacity investments globally this year.

Q4 Results and Bookings

For the quarter ended Dec. 31, 2025, ASML reported total net sales of €9.7 billion and a gross margin of 52.2%. Net income reached €2.8 billion, with basic earnings per share of €7.35. Operating margin was 35.3%, and net income accounted for 29.2% of total net sales.

Net bookings, representing new orders for the quarter, totaled €13.2 billion, a key figure the company highlighted in its investor presentation to frame its outlook.

2026 Guidance and Demand

ASML reported full-year 2025 net sales of €32.7 billion and net income of €9.6 billion. The company issued 2026 sales guidance of €34 billion to €39 billion, implying up to 19% growth from 2025. This outlook reflects management’s expectation that AI-driven chip demand will sustain capital spending.

ASML remains the sole supplier of EUV lithography systems used to produce advanced-node chips at the 7-nanometer, 5-nanometer, and 3-nanometer nodes. Chipmakers’ planned 2026 capital expenditures—TSMC $52–56 billion, Samsung about $40 billion, SK Hynix $22 billion, and Micron $20 billion—are expected to allocate roughly 25% to lithography equipment, primarily sourced from ASML. This concentration of spending helps explain the alignment between bookings and guidance.

Robust quarterly orders, strong margin performance, and concentrated chipmaker capital plans support ASML’s optimistic outlook and underscore its central role in the industry’s AI-driven capacity expansion.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Netflix Earnings Send NFLX Stock Lower

Netflix Earnings Send NFLX Stock Lower

Netflix earnings for Q1 2026 beat forecasts but weak Q2 guidance and Reed Hastings' planned June exit pushed shares lower in after-hours trading.

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos Rolls Out to Banks Amid Cyber Scrutiny

Anthropic Mythos limited Glasswing rollout to banks prompted regulator scrutiny and raised cyber and operational risk, complicating bank positioning.

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines Liquidation Looms as Fuel Costs Surge

Spirit Airlines liquidation risk rises as jet fuel may exceed year-end cash, prompting creditors' doubts and forcing traders to reassess credit exposure.

AMD Stock Rises on Bernstein Raise and AI Demand

AMD Stock Rises on Bernstein Raise and AI Demand

AMD stock rose after Bernstein raised its 12-month target as record EPYC and MI300 data-center demand boosted flows ahead of May 5 Q1 2026 earnings.

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 Launches to General Availability

Anthropic Claude Opus 4.7 went general; pricing stayed unchanged and Mythos stayed gated, a setup that could shift cloud AI costs and investor positioning.

Abbott Earnings Beat After Exact Sciences Deal

Abbott Earnings Beat After Exact Sciences Deal

Abbott earnings posted revenue and adjusted-profit beats but narrowed FY EPS guidance after the Exact Sciences acquisition, likely pressuring shares.